• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《Corona São Caetano 初级保健项目中 2073 例疑似 COVID-19 病例的临床特征和自然史:一项前瞻性队列研究》

Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.

机构信息

Faculdade de Medicina, Universidade de São Caetano do Sul, São Paulo, Brazil.

Programa de Oncovirologia, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.

出版信息

BMJ Open. 2021 Jan 12;11(1):e042745. doi: 10.1136/bmjopen-2020-042745.

DOI:10.1136/bmjopen-2020-042745
PMID:33436471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7805372/
Abstract

BACKGROUND

Despite most cases not requiring hospital care, there are limited community-based clinical data on COVID-19.

METHODS

The Corona São Caetano programme is a primary care initiative providing care to all residents with COVID-19 in São Caetano do Sul, Brazil. It was designed to capture standardised clinical data on community COVID-19 cases. After triage of potentially severe cases, consecutive patients presenting to a multimedia screening platform between 13 April and 13 May 2020 were tested at home with SARS-CoV-2 reverse transcriptase (RT) PCR; positive patients were followed up for 14 days with phone calls every 2 days. RT-PCR-negative patients were offered additional SARS-CoV-2 serology testing to establish their infection status. We describe the clinical, virological and natural history features of this prospective population-based cohort.

FINDINGS

Of 2073 suspected COVID-19 cases, 1583 (76.4%) were tested by RT-PCR, of whom 444 (28.0%, 95% CI 25.9 to 30.3) were positive; 604/1136 (53%) RT-PCR-negative patients underwent serology, of whom 52 (8.6%) tested SARS-CoV-2 seropositive. The most common symptoms of confirmed COVID-19 were cough, fatigue, myalgia and headache; whereas self-reported fever (OR 3.0, 95% CI 2.4 to 3.9), anosmia (OR 3.3, 95% CI 2.6 to 4.4) and ageusia (OR 2.9, 95% CI 2.3 to 3.8) were most strongly associated with a positive COVID-19 diagnosis by RT-PCR or serology. RT-PCR cycle thresholds were lower in men, older patients, those with fever and arthralgia and closer to symptom onset. The rates of hospitalisation and death among 444 RT-PCR-positive cases were 6.7% and 0.7%, respectively, with older age and obesity more frequent in the hospitalised group.

CONCLUSION

COVID-19 presents in a similar way to other mild community-acquired respiratory diseases, but the presence of fever, anosmia and ageusia can assist the specific diagnosis. Most patients recovered without requiring hospitalisation with a low fatality rate compared with other hospital-based studies.

摘要

背景

尽管大多数病例不需要住院治疗,但针对 COVID-19 的社区临床数据有限。

方法

São Caetano do Sul 的 Corona São Caetano 项目是一项初级保健计划,为所有 COVID-19 居民提供服务。它旨在收集社区 COVID-19 病例的标准化临床数据。对可能严重的病例进行分诊后,2020 年 4 月 13 日至 5 月 13 日期间,连续有患者通过多媒体筛查平台就诊,在家中接受 SARS-CoV-2 逆转录酶(RT)PCR 检测;对 RT-PCR 阳性患者进行为期 14 天的随访,每两天通过电话进行一次随访。对 RT-PCR 阴性患者进行额外的 SARS-CoV-2 血清学检测,以确定其感染状态。我们描述了这项前瞻性基于人群的队列的临床、病毒学和自然病史特征。

结果

在 2073 例疑似 COVID-19 病例中,有 1583 例(76.4%)接受了 RT-PCR 检测,其中 444 例(28.0%,95%CI 25.9 至 30.3)为阳性;1136 例 RT-PCR 阴性患者中有 604 例接受了血清学检测,其中 52 例(8.6%)检测到 SARS-CoV-2 血清阳性。确诊 COVID-19 最常见的症状是咳嗽、疲劳、肌痛和头痛;而自我报告的发热(OR 3.0,95%CI 2.4 至 3.9)、嗅觉丧失(OR 3.3,95%CI 2.6 至 4.4)和味觉丧失(OR 2.9,95%CI 2.3 至 3.8)与 RT-PCR 或血清学阳性 COVID-19 诊断的相关性最强。男性、年龄较大的患者、有发热和关节痛的患者以及症状出现较近的患者的 RT-PCR 循环阈值较低。444 例 RT-PCR 阳性病例中,住院率和死亡率分别为 6.7%和 0.7%,住院组中年龄较大和肥胖的患者更为常见。

结论

COVID-19 的表现与其他轻度社区获得性呼吸道疾病相似,但发热、嗅觉丧失和味觉丧失有助于特定诊断。与其他基于医院的研究相比,大多数患者无需住院即可康复,死亡率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/f2c3704bf151/bmjopen-2020-042745f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/55ff63b65ba6/bmjopen-2020-042745f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/3d5b23b7d477/bmjopen-2020-042745f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/5fd2ec43c031/bmjopen-2020-042745f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/f2c3704bf151/bmjopen-2020-042745f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/55ff63b65ba6/bmjopen-2020-042745f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/3d5b23b7d477/bmjopen-2020-042745f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/5fd2ec43c031/bmjopen-2020-042745f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a7/7805372/f2c3704bf151/bmjopen-2020-042745f04.jpg

相似文献

1
Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study.《Corona São Caetano 初级保健项目中 2073 例疑似 COVID-19 病例的临床特征和自然史:一项前瞻性队列研究》
BMJ Open. 2021 Jan 12;11(1):e042745. doi: 10.1136/bmjopen-2020-042745.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
5
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
7
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
8
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
9
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.在六个国家数字监测平台上,与 SARS-CoV-2 检测呈阳性相关的嗅觉丧失、味觉丧失和其他类似 COVID-19 的症状:一项观察性研究。
Lancet Digit Health. 2021 Sep;3(9):e577-e586. doi: 10.1016/S2589-7500(21)00115-1. Epub 2021 Jul 22.
10
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.

引用本文的文献

1
An after-action review of COVID-19 cases and mitigation measures at US Mission India, March 2020-July 2021.2020年3月至2021年7月美国驻印度使团新冠疫情病例及缓解措施的事后分析。
PLOS Glob Public Health. 2025 May 20;5(5):e0003982. doi: 10.1371/journal.pgph.0003982. eCollection 2025.
2
Thinking out of the box: revisiting health surveillance based on medical records.跳出框框思考:重新审视基于医疗记录的健康监测。
Antimicrob Steward Healthc Epidemiol. 2023 Oct 24;3(1):e185. doi: 10.1017/ash.2023.451. eCollection 2023.
3
Detailed characterization of Redondovirus in saliva of SARS-CoV-2-infected individuals in Sao Paulo, Brazil.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Longitudinal symptom dynamics of COVID-19 infection.COVID-19 感染的纵向症状动态。
Nat Commun. 2020 Dec 4;11(1):6208. doi: 10.1038/s41467-020-20053-y.
3
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
详细描述巴西圣保罗 SARS-CoV-2 感染个体唾液中的 Redondovirus。
PLoS One. 2023 Aug 31;18(8):e0291027. doi: 10.1371/journal.pone.0291027. eCollection 2023.
4
Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component.编码炎症小体成分的 CIAS1 基因多态性与严重 COVID-19 发病的关联。
Sci Rep. 2023 Jul 12;13(1):11252. doi: 10.1038/s41598-023-38095-9.
5
SARS-CoV-2 Detection and Culture in Different Biological Specimens from Immunocompetent and Immunosuppressed COVID-19 Patients Infected with Two Different Viral Strains.免疫功能正常和免疫抑制的 COVID-19 患者感染两种不同病毒株后,不同生物标本中 SARS-CoV-2 的检测和培养。
Viruses. 2023 May 29;15(6):1270. doi: 10.3390/v15061270.
6
Scale-free dynamics of COVID-19 in a Brazilian city.巴西一座城市中新冠病毒病的无标度动力学
Appl Math Model. 2023 Sep;121:166-184. doi: 10.1016/j.apm.2023.03.039. Epub 2023 Apr 21.
7
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.全球范围内,与年龄和性别相关的 COVID-19 严重程度和死亡率与合并症和吸烟状况的关系:系统评价、荟萃分析和荟萃回归。
Sci Rep. 2023 Apr 19;13(1):6415. doi: 10.1038/s41598-023-33314-9.
8
Evaluation of the effectiveness of surveillance policies to control the COVID-19 pandemic in São Paulo, Brazil.评估监控政策在控制巴西圣保罗 COVID-19 大流行方面的有效性。
Glob Health Res Policy. 2022 Aug 17;7(1):27. doi: 10.1186/s41256-022-00260-4.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of infection.拉丁美洲和加勒比地区的 COVID-19:感染流行病学中的症状和发病情况。
Curr Opin Pharmacol. 2022 Apr;63:102203. doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
4
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil.巴西 COVID-19 疫情的流行病学和临床特征。
Nat Hum Behav. 2020 Aug;4(8):856-865. doi: 10.1038/s41562-020-0928-4. Epub 2020 Jul 31.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study.巴西 COVID-19 住院死亡率的种族和地区差异:一项横断面观察性研究。
Lancet Glob Health. 2020 Aug;8(8):e1018-e1026. doi: 10.1016/S2214-109X(20)30285-0. Epub 2020 Jul 2.
7
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
8
Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases.急诊科 COVID-19 诊断:临床检查、实验室检测、影像学准确性和偏倚的范围综述。
Acad Emerg Med. 2020 Aug;27(8):653-670. doi: 10.1111/acem.14048. Epub 2020 Jul 26.
9
Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.大巴黎地区 1487 例门诊管理的 COVID-19 患者的临床特征:COVID-call 研究。
Intern Emerg Med. 2020 Aug;15(5):813-817. doi: 10.1007/s11739-020-02379-z. Epub 2020 May 30.
10
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.